Programs span familial and sporadic ALS, advancing Arbor’s strategic focus on the diseaseFirst CNS investigational new drug ...

Lillian Chiang, Founder and CEO of Doylestown, Pennsylvania-based Evrys Bio, has received the Timothy M. Block Biotech Impact ...

Epigenetic reprogramming is rewriting what we thought we knew about permanent vision loss.

The trial plans to enrol around 252 patients across at least six sites in US where Lyme disease is endemic.

("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies designed to ...

Reflector Bio, a New York-based biotechnology startup developing artificial intelligence models for drug discovery, has emerged from stealth with a... Read More ...

Five-patient Phase 1b Crohn’s disease cohort showed a 47.5% reduction in mean endoscopic disease activity and a 58.8% reduction in mean fecal ...

Immunotherapy with checkpoint inhibitors has revolutionized cancer therapy and enabled considerable therapeutic advances for ...

Pla2g2f enzyme gene preserves memory with age and resists dementia Lipid-clearing brain enzyme linked to resilient memory and ...

Researchers at Harvard Medical School's Massachusetts General Hospital have published findings in Nature Neuroscience showing that the ...

The Alzheimer's disease competitive landscape report delivers important insights into approved as well as ongoing research on 240+ pipeline Alzheimer's disease drugs, clinical strategies, upcoming ...

A D-configured gold-nanorod and cerium-oxide composite combined near-infrared heating with antioxidant activity to improve ...